Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular and Clinical Oncology is Scopus-indexed (Q3, CiteScore 3), WoS ESCI. Published by Spandidos Publications.
Checked against the index lists dated .
ISSN 2049-9450Verify ISSN ↗2049-9469Verify ISSN ↗
Publisher: Spandidos Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 263 / 428 | 38th | Q3 |
| Cancer Research | 179 / 233 | 23rd | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q3, CiteScore 3.
Molecular and Clinical Oncology is Q3 in Oncology (rank 263 of 428) and Q4 in Cancer Research (rank 179 of 233), by CiteScore 2025.
Molecular and Clinical Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3, which places it in quartile Q3 at the 38th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.511, quartile Q3, with an H-index of 27.
Molecular and Clinical Oncology is published by Spandidos Publications. Its print ISSN is 2049-9450 and its online ISSN is 2049-9469.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular and Clinical Oncology has an h-index of 56 and a 2-year mean of 2.67 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q3. On 2-year citations it ranks #136 of 424 Scopus journals in Oncology.
Molecular and Clinical Oncology published 105 papers in 2025; its busiest recent year was 2017 with 424. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from China (44.6%), Japan (30.6%) and India (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.